Grandis JR - Search Results

1

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.

Bouhaddou M, Lee RH, Li H, Bhola NE, O'Keefe RA, Naser M, Zhu TR, Nwachuku K, Duvvuri U, Olshen AB, Roy R, Hechmer A, Bolen J, Keysar SB, Jimeno A, Mills GB, Vandenberg S, Swaney DL, Johnson DE, Krogan NJ, Grandis JR. Bouhaddou M, et al. Among authors: grandis jr. JCI Insight. 2021 Oct 22;6(20):e151982. doi: 10.1172/jci.insight.151982. JCI Insight. 2021. PMID: 34546978 Free PMC article.

2

The role of peptide growth factors in head and neck carcinoma.

Grandis JR, Tweardy DJ. Grandis JR, et al. Otolaryngol Clin North Am. 1992 Oct;25(5):1105-15. Otolaryngol Clin North Am. 1992. PMID: 1408194 Review.

3

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. Cancer Res. 1993 Aug 1;53(15):3579-84. Cancer Res. 1993. PMID: 8339264

4

TGF-alpha and EGFR in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. J Cell Biochem Suppl. 1993;17F:188-91. doi: 10.1002/jcb.240531027. J Cell Biochem Suppl. 1993. PMID: 8412192 Review.

5

Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.

Drenning SD, Marcovitch AJ, Johnson DE, Melhem MF, Tweardy DJ, Grandis JR. Drenning SD, et al. Among authors: grandis jr. Clin Cancer Res. 1998 Nov;4(11):2913-21. Clin Cancer Res. 1998. PMID: 9829760

6

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD. Grandis JR, et al. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32. doi: 10.1073/pnas.97.8.4227. Proc Natl Acad Sci U S A. 2000. PMID: 10760290 Free PMC article.

7

STAT signaling in head and neck cancer.

Song JI, Grandis JR. Song JI, et al. Among authors: grandis jr. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.

8

Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

Lango MN, Shin DM, Grandis JR. Lango MN, et al. Among authors: grandis jr. Curr Opin Oncol. 2001 May;13(3):168-75. doi: 10.1097/00001622-200105000-00007. Curr Opin Oncol. 2001. PMID: 11307060 Review.

9

Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells.

Miranda MB, Dyer KF, Grandis JR, Johnson DE. Miranda MB, et al. Among authors: grandis jr. Leukemia. 2003 Feb;17(2):390-400. doi: 10.1038/sj.leu.2402779. Leukemia. 2003. PMID: 12592339

10

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, Grandis JR. Leong PL, et al. Among authors: grandis jr. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4138-43. doi: 10.1073/pnas.0534764100. Epub 2003 Mar 14. Proc Natl Acad Sci U S A. 2003. PMID: 12640143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page